DIAGNOSIS OF IMMUNE-MEDIATED INFLAMMATORY DISEASES USING MMP12 AS INDICATOR, AND MEDICINE FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES VIA MMP12 INHIBITION

CHEMICAL COMPOSITIONS AND METHODS OF USE

MARKERS FOR THE DIAGNOSIS OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER

METHODS OF EARLY IDENTIFICATION AND EARLY INTERVENTION FOR HIGH-RISK NEONATES WHO OTHERWISE WILL DEVELOP AUTISTIC SOCIAL IMPAIRMENTS LATER IN LIFE

INHIBITION OF CSF-1 or CSF-1R FOR THE TREATMENT OF MINIMAL RESIDUAL DISEASE

METHODS OF DIAGNOSING, DETERMINING THE PROGRESSION OF, AND TREATING A PROSTATE CANCER

METHOD FOR PREDICTION OF RECURRENCE OR PROGNOSIS OF DIABETIC FOOT ULCER BY USING SPECIFIC METHYLATION OF GENE

METHODS OF DETECTING PROSTATE CANCER

MASS SPECTROMETRY METHODS FOR CANCER DIAGNOSIS

HBV DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC METHODS AND PRODUCTS

DIAGNOSTIC OR PREDICTOR OF RELAPSING REMITTING MULTIPLE SCLEROSIS

PROTEIN BIOMARKERS OF INFLAMMATORY ACTIVITY IN MULTIPLE SCLEROSIS

ANTI-CLECL1 ANTIBODIES FOR TREATMENT AND PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER DISEASES

ASSAY AND RELATED METHODS, KITS AND DEVICES

METHODS FOR CANCER DETECTION AND MONITORING

USE OF HYPOXIA-INDUCIBLE FACTOR 1 ALPHA AS MARKER IN DEPRESSION RECURRENCE DIAGNOSIS

ASSESSING AND TREATING MELANOMA

METHODS FOR DETECTING DYSFUNCTIONAL NK CELLS IN LEUKEMIA PATIENTS

COMPOSITIONS AND METHODS FOR FORECASTING RESPONSE TO LUPUS NEPHRITIS (LN)THERAPY

NOVEL KINASE FUSIONS DETECTED BY LIQUID BIOPSY

METHODS FOR TREATING PATIENTS WITH AN AUTOANTIBODY-MEDIATED DISEASE

DIAGNOSIS AND TREATMENT OF ECTOPIC ENDOMETRIOSIS

BIOMARKERS AND METHODS FOR ASSESSING MYOCARDIAL INFARCTION AND SERIOUS INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS

METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE

PREDICTING CANCER RELAPSE

METHOD AND DEVICE FOR DETECTING SIGLEC12

Reagents and Methods for Monitoring Breast Cancer Therapy

BIOMARKER

LIQUID BIOPSY YIELD ENHANCEMENT

Diagnostic or predictor of relapsing remitting multiple sclerosis

INHIBITOR FOR CHRONIC MYELOID LEUKEMIA STEM CELLS

IMPROVED TREATMENT METHODS USING DMDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES, AND BIOMARKER FOR PREDICTING AND/OR OPTIMISING SAID TREATMENT METHODS

DETECTION OF A RELAPSE IN A MULTIPLE SCLEROSIS PATIENT

METHODS AND COMPOSITIONS USING NON-INVASIVE PLASMA GLYCOMIC AND METABOLIC BIOMARKERS OF POST-TREATMENT CONTROL OF HIV

NEAR INFRARED-II PROBES AS HIGH AFFINITY TARGETING IMAGING AGENTS AND USES THEREOF

Biomarkers for Identifying Relapses in Multiple Sclerosis

Methods of detecting prostate cancer

METHODS FOR PREDICTING THE RISK OF RECURRENCE AND/OR DEATH OF PATIENTS SUFFERING FROM A SOLID CANCER AFTER PREOPERATIVE ADJUVANT THERAPY AND RADICAL SURGERY

Methods for identifying progression of a primary melanoma

FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY

BCR-ABL TRUNCATION MUTATIONS

Diagnosis of autoimmune disease

Method for Monitoring of Deep Remissions in Multiple Myeloma and Other Plasma Cell Dyscrasias

SOLUBLE CD28 LEVELS DURING IMMUNOTHERAPY

CHEMICAL COMPOSITIONS AND METHODS OF USE

THERANOSTICS FOR HYPERTENSION INDUCED MYOCARDIAL MICROBLEEDS

SOLUBLE MEDIATORS FOR PREDICTING SYSTEMIC LUPUS ERYTHEMATOSUS ACTIVITY EVENTS

INFLAMMATORY BOWEL DISEASE DIAGNOSIS METHOD, DIAGNOSIS PROBE AND DIAGNOSIS KIT

METHOD OF DIAGNOSING CANCER AND DIAGNOSIS KIT USING MEASUREMENT OF NK CELL ACTIVITY

Methods of diagnosing, determining the progression of, and treating a prostate cancer

ISOLATION AND DETECTION OF EXOSOME-ASSOCIATED MICROBIOME FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES

IL-6 SIGNALING AND BREAST CANCER

Image Analysis for Breast Cancer Prognosis

Composition for diagnosing cancer using potassium channel proteins

PREDICTION OF DRUG-FREE REMISSION IN RHEUMATOID ARTHRITIS

NOVEL BIOMARKERS FOR RECURRENT TONSILLITIS

COMPUTATIONALLY DERIVED CYTOLOGICAL IMAGE MARKERS FOR PREDICTING RISK OF RELAPSE IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING BONE MARROW TRANSPLANTATION IMAGES

HBV diagnostic, prognostic, and therapeutic methods and products

METHODS OF ANALYZING DNA IN URINE

Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients

ARRAY AND METHOD OF USE

TMEM16A Modulation for Diagnostic or Therapeutic Use in Pulmonary Hypertension (PH)

Methods and compositions for nanopore sequencing

PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE IN TISSUE SAMPLES

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

Reagents and Methods for Monitoring Breast Cancer Therapy

METHOD AND SYSTEM FOR PREDICTING RECURRENCE AND NON-RECURRENCE OF MELANOMA USING SENTINEL LYMPH NODE BIOMARKERS

WBP2 AS A CO-PROGNOSTIC FACTOR WITH HER2 FOR STRATIFICATION OF PATIENTS FOR TREATMENT

METHOD OF PREDICTING RESPONSE TO THERAPY BY ASSESSING TUMOR GENETIC HETEROGENEITY

MONOCLONAL ANTIBODY FOR PREDICTING TAMOXIFEN RESPONSE IN BREAST CANCER PATIENTS

Diagnostic or predictor of relapsing remitting multiple sclerosis

Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients

Markers for the diagnosis of biochemical recurrence in prostate cancer

USE OF MEGF11 AS DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TRIPLE NEGATIVE BREAST CANCER

METHOD OF PREDICTING BREAST CANCER PROGNOSIS

Plasma MicroRNA Markers of Upper Limb Recovery Following Human Stroke

METHODS FOR THE MONITORING AND PROGNOSIS OF A CANCER

ASSAYS FOR ASSESSING NEUTRALIZING ANTIBODIES LEVELS IN SUBJECTS TREATED WITH A BIOLOGICAL DRUG AND USES THEREOF IN PERSONALIZED MEDICINE

Predicting cancer progression

TARGETING B CELLS TO ENHANCE RESPONSE TO IMMUNE CHECKPOINT BLOCKADE

IL-6 signaling and breast cancer

Compositions and methods for screening and identifying clinically aggressive prostate cancer

Method for isolating HIV reservoir cells expressing CD32a cell marker

USE OF ANTI-UCHL1 IGG PLASMA CONCENTRATION FOR DIAGNOSING IDIOPATHIC STEROID SENSITIVE NEPHROTIC SYNDROME

METHOD AND DEVICE FOR DETECTING SIGLEC12

QUANTITATIVE METHODS AND KITS FOR PROVIDING REPRODUCIBLE IHC4 SCORES

Prognostic methods and systems of treatment for acute lymphoblastic leukemia

Circulating survivin-positive exosomes

COMPOSITIONS AND METHODS FOR FORECASTING RESPONSE TO LUPUS NEPHRITIS (LN)THERAPY

METHOD OF PREDICTING BREAST CANCER PROGNOSIS

Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling

Predicting prostate cancer recurrence using a prognostic model that combines immunohistochemical staining and gene expression profiling

INDOLEAMINE-2,3-DIOXYGENASE ASSAY FOR PROSTATE CANCER DIAGNOSIS AND PROGNOSIS

Method for the detection of cells associated with the latent HIV viral reservoir using membrane biomarkers

Composition for diagnosing cancer using potassium channel proteins

Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen

Biomarkers for Detection and Treatment of Mast Cell Activity-Associated Disorders

DETERMINATION OF NON-HUMAN MAMMAL TK1 PROTEIN LEVELS

Compositions and methods for treating and preventing end stage renal disease

METHOD TO MEASURE RELATIVE UTILIZATION OF AEROBIC GLYCOLYSIS BY POSITIONAL ISOTOPIC DISCRIMINATION

System and method for determining risk of diabetes based on biochemical marker analysis

ASSAY FOR THE DIAGNOSIS OF A NEUROLOGICAL DISEASE

BCR-ABL truncation mutations

Diagnosis of autoimmune diseases

CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis

Diagnostic method

Method for predicting recurrence and progression of urothelial cancer patient after treatment

METHODS OF DIAGNOSING AND TREATING B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

TROPONIN I AND SOLUBLE UROKINASE RECEPTOR DETECTION FOR DETERMINING THE RISK OF CARDIOVASCULAR DISEASE

METHODS FOR DETECTION OF PLASMA CELL DYSCRASIA

MONOCLONAL ANTI-TK1 ANTIBODIES

METHODS AND KITS FOR PREDICTING THE RISK OF RELAPSE IN PATIENTS SUFFERING FROM IDIOPATHIC NEPHROTIC SYNDROME

Tumor mutation burden

Reagents and Methods for Monitoring Breast Cancer Therapy

Prognostic method for determining the risk of relapse in renal cancer patients with a clear cell type of renal carcinoma, stages I and II, and kit for same

Characterizing intra-tumoral heterogeneity for response and outcome prediction using radiomic spatial textural descriptor (RADISTAT)

Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus

Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

Method and kit for testing chronic myelogenous leukemia (CML), method for isolating TKI-resistant CML cells, and agent for reducing TKI-resistance of CML and method for screening the same

AN IN VITRO 3D CELL CULTURE MODEL-BASED TUMOR RELAPSE ASSAY

Monoclonal antibody for predicting tamoxifen response in breast cancer patients

Methods of determining patient response by measurement of HER-3

Methods of diagnosing infection or recurrence in a subject

SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS

Methods of identifying schizophrenia patients at risk for relapse

IL-6 signaling and breast cancer

DETECTION OF HUMAN CYTOMEGALOVIRUS IN BREAST CANCER

Methods for detecting prostate cancer by determining the ratio of early to late endosomal markers

DETECTORS OF SERUM BIOMARKERS FOR PREDICTING OVARIAN CANCER RECURRENCE

Methods used to treat cancer

PREDICTIVE MARKERS OF IBD

PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE

Method for validating existence of urinary exosome, non-invasive method for identifying urothelial cancer, and method for predicting recurrence and progression of urothelial cancer patient after treatment

Prediction of recurrence for bladder cancer by a protein signature in tissue samples

METHOD FOR DETERMINING DELETIONS IN HBV PRE-S2 REGION

SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF GASTRIC CANCER PATIENTS

Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease

Biomarker RNF6 for colorectal cancer

Cancer risk stratification based on histopathological tissue slide analysis

PREDICTION OF THE SUSCEPTIBILITY OF AN AT RISK PATIENT FOR DEVELOPING OR REDEVELOPING CLOSTRIDIUM DIFFICILE INFECTION

Methods for the monitoring and prognosis of a cancer

miR-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes

IMMUNOASSAY METHODS

Diagnostic and prognostic markers for cancer

Methods of prognosis and diagnosis of ovarian cancer

Predicting cancer progression

Method for predicting prognosis of acute myeloid leukemia relapse

Diagnostic anti-CD95L antibody

Methods and biomarkers for analysis of colorectal cancer

Diagnosis of cancer by detecting auto-antibodies against EGF-receptor

Automated analysis of circulating tumor cells

Methods for predicting post-operative recurrence of Crohn's disease

Prognosis of adverse events in patients with suspected chronic heart failure

Monoclonal anti-TK1 antibodies

Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2

Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence

Determination of the unbound free fatty acid profiles in biological and industrial specimens

Methods of diagnosing and treating B cell acute lymphoblastic leukemia

Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness

Diagnostic methods for determining prognosis of non-small cell lung cancer

Methods of using propentofylline to treat glioma and glioblastoma

Biomarkers for predicting relapse in multiple sclerosis

Methods for predicting and improving the survival of colorectal cancer patients

Method for the prognosis of survival time of a patient suffering from a solid cancer

Tumor energy metabolism profiling

Method for risk stratification in stable coronary artery disease

Methods and compositions for determining and treating relapse in inflammatory bowel disease

Methods of detecting prostate cancer

MIR-193A-3P and associated genes predict tumorigenesis and chemotherapy outcomes

Anti-FGFR2 antibodies and pharmaceutical compositions thereof

Image analysis for breast cancer prognosis

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

Biomarkers in inflammatory bowel disease

Method for detecting neurological disease accompanied by inflammation and/or demyelination

Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis

Means and Methods for Diagnosing Recurrence of Prostate Cancer After Prostatectomy

Functional assay for cancer recurrence and malignant potential

METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION

Detectors of serum biomarkers for predicting ovarian cancer recurrence

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

Anti-FGFR2 antibodies and methods of use thereof for treating cancer

METHOD AND SYSTEM TO DETECT AND DIAGNOSE ALZHEIMER'S DISEASE

TEST FOR DIAGNOSING RESISTANCE TO AZACITIDINE

Method for risk stratification in stable coronary artery disease

Prognosis of adverse events in patients with suspected chronic heart failure

Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease

Antibodies and method for determining deletions in HBV pre-S region

Ganglioside GD2 as a marker and target on cancer stem cells

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR CANCER

Multi-biomarker-based outcome risk stratification model for adult septic shock

System and method for determining risk of diabetes based on biochemical marker analysis

Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis

Methods of determining efficacy of treatment in a subject having heart failure

Prediction of recurrence for bladder cancer by a protein signature in tissue samples

Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer

Methods for assessing cancer recurrence

Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity

miR-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes

Quantitative methods and kits for providing reproducible IHC4 scores

Bladder cancer diagnosis composition containing APE1/Ref-1 and bladder cancer diagnostic kit using same

PREDICTIVE BIOMARKERS FOR BREAST CANCER

Methods for identifying leukemia stem cells and distinguishing them from normal hematopietic stem cells in patients with acute myeloid leukemia: uses in diagnosis, treatment, and research

HER-3 antibodies and methods of use

Gene Based Prediction of PSA Recurrence for Clinically Localized Prostate Cancer Patients

EPITHELIAL BIOMARKERS FOR CANCER PROGNOSIS

Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING CEA-EXPRESSING CANCERS

Method for diagnosing malignant tumor

Diagnostic and Prognostic Markers for Cancer

METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

DIAGNOSING PROSTATE CANCER RELAPSE

Diagnostic and Prognostic Markers for Cancer

CA-125 Immune Complexes as Biomarkers of Ovarian Cancer

Inhibition of the interaction between 5T4 oncofoetal glycoproteins and CXC chemokine receptors as a method of identifying chemotaxis inhibitors

Methods predicting risk of an adverse clinical outcome

STEROID RECEPTOR ASSAYS

METHOD AND SYSTEM TO DETECT AND DIAGNOSE ALZHEIMER'S DISEASE

SERUM BIOMARKERS FOR MELANOMA METASTASIS

DIAGNOSIS OF IN SITU AND INVASIVE BREAST CANCER

GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-HER3 ANTIBODIES

GENE SIGNATURE IS ASSOCIATED WITH EARLY STAGE RECTAL CANCER RECURRENCE

METHODS AND COMPOSITIONS FOR THE DETECTION OF LUNG CANCERS

BIOMARKERS AND USES THEREOF IN PROGNOSIS AND TREATMENT STRATEGIES FOR RIGHT-SIDE COLON CANCER DISEASE AND LEFT-SIDE COLON CANCER DISEASE

Methods for inhibiting peritoneal dissemination of cancer cells

METHODS OF PREDICTING THE RISK OF RECURRENCE OF CANCER

Method for risk stratification in stable coronary artery disease

METHODS AND MATERIALS FOR ASSESSING PROSTATE CANCER RECURRENCE AND REDUCING MESOTRYPSIN ACTIVITY

Phosphodiesterase 4D7 as prostate cancer marker

PROCESS FOR TUMOUR CHARACTERISTIC AND MARKER SET IDENTIFICATION, TUMOUR CLASSIFICATION AND MARKER SETS FOR CANCER

BIOMARKER FOR MONITORING PATIENTS

Methods for detection of gastric cancer

METHODS AND MATERIALS FOR USING NKAP POLYPEPTIDE EXPRESSION LEVELS OR PATTERNS TO DETECT OR ASSESS CANCER

Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof

METHODS AND KITS USED IN IDENTIFYING GLIOBLASTOMA

METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN CANCER

Method for judging risk of cancer recurrence, computer program, and computer system

USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT

Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia

METHOD FOR DIAGNOSIS OF POST-OPERATIVE RECURRENCE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

EBI3, DLX5, NPTX1 AND CDKN3 FOR TARGET GENES OF LUNG CANCER THERAPY AND DIAGNOSIS

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

Compositions and Methods for the Treatment and Diagnosis of Cancer

Diagnostic methods for determining prognosis of non-small cell lung cancer

Method of assessing cancer status in a breast cancer patient

BCR-ABL truncation mutations

METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

Use of CFH or ApoH as a biochemical diagnostic marker for complete remission in acute myeloid leukemia

BREAST CANCER EXPRESSION PROFILING

Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling

Pharmaceutical composition for inhibiting peritoneal dissemination

Use of HE4 for assessment of breast cancers

PREDICTING CANCER PROGRESSION

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers

Collecting ovarian cancer stem cells from ovarian cancer cells

METHOD FOR ASSESSING POTENTIAL FOR TUMOR DEVELOPMENT AND METASTASIS

ASSESSING OUTCOMES FOR BREAST CANCER PATIENTS

Method for early detection of cancers

EMX2 in cancer diagnosis and prognosis

Method for prediction of postoperative prognosis and diagnosis kit

Methods of determining patient response by measurement of Her-3

NOVEL SECRETED PROTEINS OF ADIPOCYTES FOR DIAGNOSTIC PURPOSES

Method of supporting a diagnosis of a risk of cancer recurrence, and a device of supporting a diagnosis of a risk of cancer recurrence

Prognostic panel for urinary bladder cancer

Method for early determination of recurrence after therapy for prostate cancer

DNA Repair Proteins Associated With Triple Negative Breast Cancers and Methods of Use Thereof

METHOD FOR DETERMINING RISK OF CANCER RELAPSE AND COMPUTER PROGRAM PRODUCT

HIGHLY SENSITIVE SYSTEM AND METHODS FOR ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA)

Clinical Intervention Directed Diagnostic Methods

Soluble ErbB3 and treatment of cancer

Predicting cancer progression

Method and compositions for detection of liver cancer

Athletic performance and technique monitoring

Athletic performance and technique monitoring

Athletic performance and technique monitoring